. 2022 Mar 15;6(6):1742–1753. doi: 10.1182/bloodadvances.2021004821
© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Figure 3.
Survival outcomes. EFS (A) and OS (B).